| Roger obtained his PhD from the Department of Chemistry at the University of Ottawa in carbohydrate chemistry synthesizing glycoproteins as biological antifreezes. He then pursued his postdoctoral training in chemical engineering where he developed various polysaccharide-based biomaterials for stem cell transplantation into the injured spinal cord and also for in vitro 3D cell culture. This latter application led to a collaborative effort where he then also worked at the Ottawa Hospital Research Institute to use these biomimetic and stimuli-responsive biomaterials to culture and screen drugs in metastatic lung cancer-like cells. He has been a Research Scientist in the Glycobiology lab at the Regulatory Research Division at Health Canada since November 2017. |